Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Unilever PLC (ULVR)

Amsterdam
Symbol
Exchange
Currency
ULVRAmsterdamEUR
ULVRlBATS EuropeGBP
UNAaBATS EuropeEUR
ULVRLondonGBP
ULVRXetraEUR
ULBuenos AiresARS
ULVRViennaEUR
ULVRPragueCZK
Currency in EUR
Disclaimer
44.84
-0.21(-0.47%)
Real-time Data

ULVR Price Commentary

follow me
how i invest in uniliver
Have the earnings been leaked?
£24
It's weird. Someone who was very bearish on this stock deleted all his messages. And now it looks as though I was just talking to myself in this l forum all the time lol
on the up today
Getting close to me target. Your dislikes won't stop this from moving up
a BUY signal on Market Mìracle advisor with target 48.67
Keep buying will return above 4k soon.
Ever heard the saying ' while the small fish are fighting the bigger fish will eat them all'. It won't be long before the real heavyweights wade in...J&J, P&G, Nestle etc. Then it could be goodbye GSK and Unilever.
Ulvr is always in the business of acquisition (they bought 6 major brands since 2020) and GSK consumer healthcare potentially allows it to branch out their f&b range which I think could be interesting for them to grow their top line. They made a sneaky undervalued offer to GSK as it was no secret the latter wants to get rid of its consumer healthcare business
If its overvalued GSK would have accepted on the spot!
If this m&a is successful, ulvr will probably be the largest company by market cap in ftse100. BTW, I sold have my positions in GSK to buy Ulvr
The GSK consumer healthcare bid is just noise and media made it sound like a blunder. If one is relatively familiar with Ulvr, you will know its a norm for them to acquire assets. It is only a bad practice if one over pays for it. Oh, ulvr made 6 acquisitions since 2020 and this will be another one. https://www.unilever.com/investors/news-and-announcements/acquisitions-disposals/
good if you have a long term view strategy for this stock - buy in tranche. It's a sale - at present!
Keep buying the dip
Let's see. I expect this to go back to 4,000 "quickly"
In his latest research note, analyst Faham Baig confirms his positive recommendation. The broker Credit Suisse is keeping its Buy rating. The target price continues to be set at GBX 4800.
Overaction from GSK bid rejection. Good time to top up
it's opportunity to add more... thank you!
run!
There is an indication of purchase on Market Miracle Advisor, is the second in a few days we hope that you start to rise seriously
Just topped up crazy cheap
it has been crazy cheap for 10 months now. the most boring share ever.
All shares heading lower on back of omicron wild virus
ULVR is today buy signal with possible take profit price 4163Get Ytd Trade on app store for daily buy signals and invest to earn not to lose
Well that didnt work out, did it.
3853.00p and all previous post stating Value under 4000 so if you are all BUYING why is the Share FALLING...I see value at 3500p
Super strong buy. Great company good divi. And brokers have it as sell!?!?!
why are the brokers stating SELL something must be up ?
their supply chain/ production cost inflation supposedly running at 8-10% and they cant immediately (or possibly ever) recoup this from customers. Direct hit on their profitability.
I'm in at below 4 nice nest egg.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.